Tel Aviv University

Grantee website Tel Aviv, Israel
to generate immunological target values that new vaccines against Shigella, a major cause of moderate and severe diarrhea globally, need to meet to advance along the clinical development pipeline.
Global Health
MARCH 2018
Region served
Committed amount
Grant topic
Enteric and Diarrheal Diseases
Duration (months)
Grantee location
Tel Aviv, Israel

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.